These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 8639971)

  • 1. Aminoguanidine does not inhibit aldose reductase activity in galactose-fed rats.
    Dvornik D; Hohman TC; Basso MD
    J Diabetes Complications; 1996; 10(1):23-30. PubMed ID: 8639971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glycolytic pathway, redox state of NAD(P)-couples and energy metabolism in lens in galactose-fed rats: effect of an aldose reductase inhibitor.
    Obrosova I; Faller A; Burgan J; Ostrow E; Williamson JR
    Curr Eye Res; 1997 Jan; 16(1):34-43. PubMed ID: 9043821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An aldose reductase inhibitor and aminoguanidine prevent vascular endothelial growth factor expression in rats with long-term galactosemia.
    Frank RN; Amin R; Kennedy A; Hohman TC
    Arch Ophthalmol; 1997 Aug; 115(8):1036-47. PubMed ID: 9258227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of diabetic vascular dysfunction by guanidines. Inhibition of nitric oxide synthase versus advanced glycation end-product formation.
    Tilton RG; Chang K; Hasan KS; Smith SR; Petrash JM; Misko TP; Moore WM; Currie MG; Corbett JA; McDaniel ML
    Diabetes; 1993 Feb; 42(2):221-32. PubMed ID: 7678825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Syntheses of tolrestat analogues containing additional substituents in the ring and their evaluation as aldose reductase inhibitors. Identification of potent, orally active 2-fluoro derivatives.
    Wrobel J; Millen J; Sredy J; Dietrich A; Gorham BJ; Malamas M; Kelly JM; Bauman JG; Harrison MC; Jones LR
    J Med Chem; 1991 Aug; 34(8):2504-20. PubMed ID: 1908522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the effects of Zopolrestat and Sorbinil on lens myo-inositol influx.
    Beyer-Mears A; Diecke FP; Mistry K; Cruz E
    Pharmacology; 1997 Feb; 54(2):76-83. PubMed ID: 9088040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new approach against sugar cataract through aldose reductase inhibitors.
    Banditelli S; Boldrini E; Vilardo PG; Cecconi I; Cappiello M; Dal Monte M; Marini I; Del Corso A; Mura U
    Exp Eye Res; 1999 Nov; 69(5):533-8. PubMed ID: 10548473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impairment of afferent arteriolar myogenic responsiveness in the galactose-fed rat is prevented by tolrestat.
    Forster HG; ter Wee PM; Hohman TC; Epstein M
    Diabetologia; 1996 Aug; 39(8):907-14. PubMed ID: 8858212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel spirosuccinimide aldose reductase inhibitors derived from isoquinoline-1,3-diones: 2-[(4-bromo-2-fluorophenyl)methyl]-6- fluorospiro[isoquinoline-4(1H),3'-pyrrolidine]-1,2',3,5'(2H)-tetrone and congeners. 1.
    Malamas MS; Hohman TC; Millen J
    J Med Chem; 1994 Jun; 37(13):2043-58. PubMed ID: 8027986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tolrestat pharmacokinetics in rat peripheral nerve.
    Dvornik D; Millen J; Hicks DR; Kraml M
    J Diabetes Complications; 1994; 8(1):18-26. PubMed ID: 8167382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relative contributions of advanced glycation and nitric oxide synthase inhibition to aminoguanidine-mediated renoprotection in diabetic rats.
    Soulis T; Cooper ME; Sastra S; Thallas V; Panagiotopoulos S; Bjerrum OJ; Jerums G
    Diabetologia; 1997 Oct; 40(10):1141-51. PubMed ID: 9349594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of seven days of galactose feeding and aldose reductase inhibition on mast cells and vessel morphometry in rat sciatic nerve.
    Brett FM; Kalichman MW; Calcutt NA; Mizisin AP
    J Neurol Sci; 1996 Sep; 141(1-2):6-12. PubMed ID: 8880685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of cataract development in severely galactosemic rats by the aldose reductase inhibitor, tolrestat.
    Simard-Duquesne N; Greselin E; Gonzalez R; Dvornik D
    Proc Soc Exp Biol Med; 1985 Apr; 178(4):599-605. PubMed ID: 3983136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of nitric oxide formation by guanidines.
    Hasan K; Heesen BJ; Corbett JA; McDaniel ML; Chang K; Allison W; Wolffenbuttel BH; Williamson JR; Tilton RG
    Eur J Pharmacol; 1993 Nov; 249(1):101-6. PubMed ID: 7506664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intrinsic inhibition of aldose reductase.
    Kador PF; Sun G; Rait VK; Rodriguez L; Ma Y; Sugiyama K
    J Ocul Pharmacol Ther; 2001 Aug; 17(4):373-81. PubMed ID: 11572468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polyol pathway activity in nervous tissues of diabetic and galactose-fed rats: effect of dietary galactose withdrawal or tolrestat intervention therapy.
    Sredy J; Sawicki DR; Notvest RR
    J Diabet Complications; 1991; 5(1):42-7. PubMed ID: 1830318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relative importance of aldose reductase versus nonenzymatic glycosylation on sugar cataract formation in diabetic rats.
    Kador PF; Lee JW; Fujisawa S; Blessing K; Lou MF
    J Ocul Pharmacol Ther; 2000 Apr; 16(2):149-60. PubMed ID: 10803425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The inhibitory effect of aldose reductase inhibitor for proliferation in the lens epithelial cells of rat sugar cataract].
    Morikubo S; Takamura Y; Kubo E; Tsuzuki S; Akagi Y
    Nippon Ganka Gakkai Zasshi; 2003 Oct; 107(10):565-70. PubMed ID: 14598706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitory effects of chlorogenic acid on aldose reductase activity in vitro and cataractogenesis in galactose-fed rats.
    Kim CS; Kim J; Lee YM; Sohn E; Jo K; Kim JS
    Arch Pharm Res; 2011 May; 34(5):847-52. PubMed ID: 21656371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of macrophage chemotaxis and peripheral nerve regeneration in normal and hyperglycemic rats by the aldose reductase inhibitor Tolrestat.
    Calcutt NA; McMurray HF; Moorhouse DF; Bache M; Parthasarathy S; Powell HC; Mizisin AP
    Exp Neurol; 1994 Aug; 128(2):226-32. PubMed ID: 8076666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.